Capital Ix Sofinnova - Net Worth and Insider Trading
Capital Ix Sofinnova Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Capital Ix Sofinnova owns 1 companies in total, including CinCor Pharma Inc (CINC) .
Click here to see the complete history of Capital Ix Sofinnova’s form 4 insider trades.
Insider Ownership Summary of Capital Ix Sofinnova
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CINC | CinCor Pharma Inc | 2022-01-06 | 10 percent owner |
Capital Ix Sofinnova Trading Performance
Capital Ix Sofinnova Ownership Network
Ownership Network List of Capital Ix Sofinnova
Ownership Network Relation of Capital Ix Sofinnova
Capital Ix Sofinnova Owned Company Details
What does CinCor Pharma Inc do?
Who are the key executives at CinCor Pharma Inc?
Capital Ix Sofinnova is the 10 percent owner of CinCor Pharma Inc. Other key executives at CinCor Pharma Inc include director & 10 percent owner James Healy , 10 percent owner Sofinnova Management X-a, L.l.c. , and EVP & Chief Financial Officer Michael Wayne Kalb .
CinCor Pharma Inc (CINC) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of CinCor Pharma Inc (CINC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of CinCor Pharma Inc (CINC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
CinCor Pharma Inc (CINC)'s detailed insider trading history can be found in Insider Trading Tracker table.
CinCor Pharma Inc Insider Transactions
Capital Ix Sofinnova Mailing Address
Above is the net worth, insider trading, and ownership report for Capital Ix Sofinnova. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Capital Ix Sofinnova's mailing address is: Paris I0 75009.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
